← Back to Analyst Consensus 
BLTE Buy
BELITE BIO, INC
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 9, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Sep 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 4, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Aug 14, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 14, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Aug 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 26, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 21, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 3, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 3, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 3, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Jan 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $185 | 44% |
| Jan 26, 2026 | B of A Securities | initiate | — → Buy | $195 | 53% |
| Jan 6, 2026 | Morgan Stanley | initiate | — → Overweight | $191 | 54% |
| Dec 2, 2025 | Mizuho | upgrade | Neutral → Outperform | $194 | 52% |
| Dec 1, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $185 | 44% |
| Nov 20, 2025 | Mizuho | initiate | — → Neutral | $105 | 52% |
| Oct 31, 2025 | Benchmark | maintain | Buy → Buy | $132 | 54% |
| Sep 15, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $98 | 44% |
| Jul 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 15, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| May 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Mar 26, 2025 | Benchmark | reiterate | Buy → Buy | $80 | 54% |
| Mar 18, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Mar 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Jan 21, 2025 | Benchmark | maintain | Buy → Buy | $79 | 54% |
| Nov 15, 2024 | Maxim Group | maintain | Buy → Buy | $110 | 42% |
| Nov 13, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $100 | 44% |
| Sep 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $60 | 44% |
| Aug 13, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $60 | 44% |
| Aug 13, 2024 | Benchmark | reiterate | Buy → Buy | $57 | 54% |
| Jun 20, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jun 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| May 16, 2024 | Benchmark | reiterate | Buy → Buy | $57 | 54% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| May 15, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Mar 22, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $59 | 44% |
| Mar 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| Dec 27, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| Dec 14, 2023 | Maxim Group | initiate | — → Buy | $60 | 42% |
| Nov 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $59 | 44% |
| Nov 7, 2023 | Benchmark | reiterate | Buy → Buy | $57 | 54% |
| Nov 6, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $59 | 44% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Jul 28, 2023 | Cantor Fitzgerald | initiate | — → Overweight | $43 | 50% |
| Jul 26, 2023 | SVB Leerink | initiate | — → Outperform | $25 | — |
Price Target Trend
Jul 2, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days